Sonic Healthcare boss Colin Goldschmidt says as PCR testing falls away in various nations, the diagnosis of other diseases, the ageing population and preventative medicine will underpin the growth of its testing business.
Dr Goldschmidt told The Australian Financial Review that over the coming 12 to 18 months there will be a bounce back of routine testing services for the pathology giant, as patients go back to GPs and elective surgeries restart.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
